Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Related Articles by Review for PubMed (Select 12716797)

1.

Polypharmacy and medication adherence in patients with type 2 diabetes.

Grant RW, Devita NG, Singer DE, Meigs JB.

Diabetes Care. 2003 May;26(5):1408-12.

PMID:
12716797
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
3.

Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists.

Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens J, Biot Y.

J Clin Pharm Ther. 2006 Oct;31(5):409-19. Review.

PMID:
16958818
4.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
5.

Medication taking and diabetes: a systematic review of the literature.

Odegard PS, Capoccia K.

Diabetes Educ. 2007 Nov-Dec;33(6):1014-29; discussion 1030-1. Review.

PMID:
18057270
6.

Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus.

Rubin RR.

Am J Med. 2005 May;118 Suppl 5A:27S-34S. Review.

PMID:
15850551
7.

The economic rationale for adherence in the treatment of type 2 diabetes mellitus.

Wild H.

Am J Manag Care. 2012 Apr;18(3 Suppl):S43-8. Review.

8.

Patient adherence to medication requirements for therapy of type 2 diabetes.

Bailey CJ, Kodack M.

Int J Clin Pract. 2011 Mar;65(3):314-22. doi: 10.1111/j.1742-1241.2010.02544.x. Review.

PMID:
21314869
10.

Does intervention by an allied health professional discussing adherence to medicines improve this adherence in Type 2 diabetes?

Doggrell SA.

Diabet Med. 2010 Dec;27(12):1341-9. doi: 10.1111/j.1464-5491.2010.03137.x. Review.

PMID:
21059085
11.
12.

Methodological issues in diabetes research. Measuring adherence.

Johnson SB.

Diabetes Care. 1992 Nov;15(11):1658-67. Review.

PMID:
1468298
13.

Optimizing adherence to pharmaceutical care plans.

Nichols-English G, Poirier S.

J Am Pharm Assoc (Wash). 2000 Jul-Aug;40(4):475-85. Review.

PMID:
10932456
14.

Problems of polypharmacy.

Shakib S.

Aust Fam Physician. 2002 Feb;31(2):125-8. Review.

PMID:
11917821
15.

Two character traits associated with adherence to long term therapies.

Reach G.

Diabetes Res Clin Pract. 2012 Oct;98(1):19-25. doi: 10.1016/j.diabres.2012.06.008. Epub 2012 Jul 13. Review.

PMID:
22795909
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk